Patent 12004938 was granted and assigned to Shockwave Medical, Inc. on June, 2024 by the United States Patent and Trademark Office.
Described herein are devices, systems, and methods for modifying blood flow and improving tissue oxygenation in an individual. More specifically, described herein are flow modifying implants, delivery systems, and methods of treatment using flow modifying implants. Also described herein are methods for preventing reperfusion injury in an individual using a flow modifying implant to prevent the reperfusion injury.